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a b s t r a c t 
Hallucinogenic agents have been proposed as potent antidepressants; this includes the serotonin (5-HT) receptor 
2A agonist psilocybin. In human subjects, psilocybin alters functional connectivity (FC) within the default-mode 
network (DMN), a constellation of inter-connected regions that displays altered FC in depressive disorders. In this 
study, we investigated the effects of psilocybin on FC across the entire brain with a view to investigate underlying 
mechanisms. Psilocybin effects were investigated in lightly-anaesthetized mice using resting-state fMRI. Dual- 
regression analysis identified reduced FC within the ventral striatum in psilocybin- relative to vehicle-treated 
mice. Refinement of the analysis using spatial references derived from both gene expression maps and viral tracer 
projection fields revealed two distinct effects of psilocybin: it increased FC between 5-HT-associated networks and 
cortical areas, including elements of the murine DMN, thalamus, and midbrain; it decreased FC within dopamine 
(DA)-associated striatal networks. These results suggest that interactions between 5-HT- and DA-regulated neural 
networks contribute to the neural and therefore psychological effects of psilocybin. Furthermore, they highlight 
how information on molecular expression patterns and structural connectivity can assist in the interpretation of 
pharmaco-fMRI findings. 
1. Introduction 
Psychiatric disorders are associated with changes in the status 
of specific neurotransmitter systems, including those of serotonin 
(5-hydroxytryptamine, 5-HT) and dopamine (DA). Recently, psilocy- 
bin, a psychedelic compound derived from ”magic mushrooms ” with 
high affinity to the 5-HTA receptor ( Halberstadt and Geyer, 2011 ; 
Nichols, 2004 ), has gained in research interest due to its potential to alle- 
viate depression and anxiety ( Carhart-Harris et al., 2017 ; Griffiths et al., 
2016 ; Grob et al., 2011 ). Whilst the primary target of its active metabo- 
lite psilocin is the 5-HT2A receptor and it binds to a lesser extent to 
receptor 5-HT1A, psilocybin has also been shown to induce DA release 
in the nucleus accumbens in rats ( Sakashita et al., 2015 ) and to reduce 
11 C-raclopride binding to the D2 receptor in the caudate-putamen in 
humans ( Vollenweider, 1999 ). 
The direct and indirect actions of psilocybin on specific monoamine 
neurotransmitter systems result in downstream metabolic and physio- 
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logical effects on the brain. Thus, psilocybin increases global energy 
metabolism indicated by elevated glucose utilization rates in the fronto- 
medial, frontolateral and anterior cingulate cortices as well as in basal 
ganglia ( Vollenweider et al., 1997 ). Also, somewhat counterintuitively, 
reduced cerebral blood flow (CBF) in several brain regions including 
cingulate cortex, thalamus and striatum, has been reported ( Carhart- 
Harris et al., 2012 ). In blood oxygen level-dependent functional mag- 
netic resonance imaging (BOLD fMRI) studies, psilocybin decreased 
functional connectivity (FC) within the default-mode network (DMN), 
and between the anterior DMN and task-positive networks ( Carhart- 
Harris et al., 2013 , 2012 ; Roseman et al., 2014 ). Psilocybin, therefore, 
impacts on FC in various networks throughout the human brain, with 
the main effect centered on the DMN. This is consistent with the concept 
that psilocybin’s psychoactive effects are mediated by networks under- 
lying self-referential processing ( Carhart-Harris et al., 2014 ). The mech- 
anisms, whereby psilocybin acts on functional activity within the DMN 
and other resting-state networks (RSNs), remain poorly understood, in- 
cluding how the 5-HT system is involved. 
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The contributions of the monoamine systems 5-HT and DA to FC are 
challenging to understand. The midbrain nuclei hosting 5-HT (raphe nu- 
clei) and DA (ventral tegmental area, substantia nigra pars compacta) 
cell bodies are not included in canonical RSNs ( Damoiseaux et al., 2006 ). 
Using BOLD fMRI, correlational analysis of signal traces extracted from 
midbrain nuclei typically fails to capture evidence of functional cou- 
pling to distal regions. Integrating complementary information with FC 
analysis might overcome this limitation and reveal contributions of mid- 
brain nuclei to FC. In mouse models, integration of whole-brain imaging 
with region-specific gene expression ( Hawrylycz et al., 2012 ; Lein et al., 
2007 ; Ng et al., 2009 ) and axonal projection maps ( Oh et al., 2014 ) de- 
rived from the Allen Institute for Brain Science (AIBS) offers the oppor- 
tunity to investigate the molecular neuropharmacology of psychoactive 
agents in spatio-temporal dimensions. 
Here we hypothesized that i) acute psilocybin administration in 
mice increases FC within and between elements of the rodent DMN 
( Gozzi and Schwarz, 2016 ; Sforazzini et al., 2014 ; Stafford et al., 2014 ), 
and ii) gene expression and axonal projection maps related to spe- 
cific monoamine systems can be used to identify specific contributions 
of these systems to the psilocybin-induced changes in FC pattern ob- 
served. To test these hypotheses, we acquired resting-state fMRI data 
from mice treated with psilocybin or vehicle. Conventional data analy- 
sis did not reveal any drug-induced alterations within elements of the 
rodent DMN. Rather, we observed a significant decrease in striatal FC, 
pronounced in the ventral striatum, following psilocybin. Gene expres- 
sion maps for the 5-HT2A receptor or the D2 receptor, and axonal pro- 
jection field maps for dorsal raphe nucleus (DRN) 5-HT neurons and 
ventral tegmental area (VTA) DA neurons, were used as spatial refer- 
ences for identifying 5-HT and DA contributions to the RSN changes in- 
duced by psilocybin. This novel iterative approach revealed psilocybin 
effects not evident from conventional fMRI analysis and demonstrated 
that psilocybin does act on FC within the rodent DMN, albeit to a lesser 
extent compared to its FC effects in the ventral striatum. These find- 
ings provide new translational insights into the neuropharmacology of 
psilocybin. 
2. Material and methods 
2.1. Animal preparation and psilocybin administration 
This study was conducted in accordance with federal guidelines and 
under a license from the Zürich Cantonal Veterinary Office (149/2015). 
A total of 50 young-adult male C57BL/6 mice (Janvier, Le Genest-St Isle, 
France) weighing 25 ± 1.2 g were studied. Animals were maintained in 
standard housing with food and water available ad libitum and in a 
reversed 12:12 day/night cycle (light off: 07:00–19:00 h). Anaesthesia 
was induced with isoflurane 3.5% in a mixture of 20% O2 and 80% 
air. Isoflurane was reduced to 2%, animals were then intubated endo- 
tracheally and ventilated mechanically at 80 breaths/min, positioned 
on an MR-compatible cradle, and a cannula was positioned in the tail 
vein. Psilocybin was dissolved in sterile water with tartaric acid and 
infused i.v. during 5 min with either 1 mg/kg ( n = 13) or 2 mg/kg 
( n = 12) or vehicle only ( n = 15). These doses were chosen because 
they were demonstrated previously to elicit hallucinogen-specific be- 
haviour in mice ( González-Maeso et al., 2007 ). In contrast, doses com- 
parable to those used in humans failed to elicit detectable hemodynamic 
changes in the resting BOLD signal in rats ( Carhart-Harris et al., 2012 ; 
Spain et al., 2015 ). Following the infusion, a bolus of medetomidine 
(0.05 mg/kg, Domitor, medetomidine hydrochloride; Pfizer Pharmaceu- 
ticals, Sandwich, UK) together with muscle-relaxant pancuronium bro- 
mide (0.2 mg/kg, Sigma-Aldrich, Steinheim, Germany) was injected i.v. 
and isoflurane was reduced to 1.5%. After 5 min, isoflurane was fur- 
ther reduced to 0.5% and medetomidine (0.1 mg/kg/h) and pancuro- 
nium bromide (0.4 mg/kg/h) were infused during the remainder of the 
imaging acquisition protocol as in ( Grandjean et al., 2014 ). Functional 
imaging began 20 min after completion of the psilocybin or vehicle in- 
fusion. To test for potential effects of psilocybin on cardiovascular func- 
tion that would lead to confounding effects on brain FC, in a separate 
group of mice ( n = 10) electrocardiogram recordings were made whilst 
otherwise applying the same protocol as for the MRI experiment. Elec- 
trocardiogram recordings were performed using 3 sets of electrodes (SA 
instruments Inc, Stony Brook, NY, USA) inserted into the front paws 
and left hind paw. All animals in the study were included in the data 
analysis. 
2.2. Image acquisition 
MRI experiments were conducted using a Bruker Biospec 94/30 
small animal MR system (Bruker BioSpin MRI, Ettlingen, Germany) op- 
erating at 400 MHz (9.4 T). A linearly polarized volume resonator was 
used for transmission, together with a four-element receiver-only cryo- 
genic phased array coil (Bruker BioSpin AG, Fällanden, Switzerland). A 
multi-echo gradient-echo planar imaging (ME-EPI) sequence was used 
to acquire BOLD fMRI with: repetition time 1500 ms, echo time [11, 17, 
23] ms, flip angle 60°, matrix size 60 × 30, field of view 18.2 × 9 mm 2 , 
number of coronal slices 20, slice thickness 0.3 mm, slice gap 0.05 mm, 
800 vol., acceleration factor 1.4, horizontal field of view saturation 
slice to mask the lower portion of the mouse head, and 250,000 Hz 
bandwidth. Representative images indicating minimal signal drop out 
and distortions are shown in the supplement (Fig. S1). Images were 
pre-processed in AFNI (AFNI_16.1.26, https://afni.nimh.nih.gov/ ), us- 
ing the meica.py script ( Kundu et al., 2012 ) to reconstruct the ME-EPI 
and remove non-BOLD noise contributions. The script removes spikes 
( 3dDespike ), performs motion correction ( 3dvolreg ), spatial smoothing at 
0.3 mm (3dBlurInMask), and temporal detrending ( 3dDetrend ). The esti- 
mated averaged framewise displacement was below 5% of the in-plane 
voxel dimension, indicative of minimal movement artefact. Finally, 
BOLD components were separated from non-BOLD components based 
on echo-time dependency, and non-BOLD components were regressed 
out. Reconstructed ME-EPIs were normalized into a study EPI template 
generated with ANTS (V2.1, http://picsl.upenn.edu/software/ants/ , 
buildtemplateparallel.sh ), prior to being registered into the AMBMC 
template ( www.imaging.org.au/AMBMC/AMBMC ) using linear affine 
and nonlinear SyN diffeomorphic transformation ( antsIntroduction.sh ) 
( Avants et al., 2011 ). 
2.3. Experimental design and statistical analysis 
The complete dataset used in this study is fully 
available online (PROJECT_ID: Mouse_rest_psilocybin, 
https://openneuro.org/datasets/ds001725 ) 
Acquisition was carried out in two separate subsets with respect to 
the experimenter (JG or DB): subset 1 comprised vehicle = 8, 1 mg/kg 
n = 6, 2 mg/kg n = 5 mice, and subset 2 comprised vehicle n = 7, 1 mg/kg 
n = 7, 2 mg/kg n = 7) mice. Voxel-based within-network functional con- 
nectivity analysis was carried out using a dual-regression framework 
( Filippini et al., 2009 ). This is justified by the robustness of the method 
( Grandjean et al., 2020 ), and its versatility with respect to anatomi- 
cal assumptions. Briefly, spatially delineated non-thresholded reference 
maps are used to extract a weighted average BOLD time course for each 
scan. A general linear model was used to regress these time courses into 
the individual scans, to obtain parameter estimate maps indicative of 
network strength at every voxel for each corresponding reference map. 
The spatial reference maps used to delineate networks to be tested in the 
dual-regression analyses were either 17 references RSNs as determined 
with group independent component analysis (ICA, detailed in Fig. 3 a) 
in ( Zerbi et al., 2015 ), in-situ hybridization (ISH) gene expression maps 
( Lein et al., 2007 ), or viral tracer maps ( Oh et al., 2014 ). To confirm the 
spatial distribution of the ventral striatum network, seed-based maps 
were obtained by extracting time courses from a selected seed region in 
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the ventral striatum, corresponding to the peak psilocybin effect in the 
dual-regression analysis. The BOLD signal from the seed regressing them 
in a general linear model into individual scans from the vehicle group to 
obtain parameter estimate maps denoting FC relative to the seed region. 
Group-level statistical analysis was carried out with a non-parametric 
permutation test (5000 permutations), with parameter estimate maps 
from mice administered with either psilocybin 1 mg/kg or 2 mg/kg 
compared to vehicle, or a combined psilocybin group (1 and 2 mg/kg) 
compared to vehicle. The statistical correction for multiple hypothesis 
testing was carried out in two stages: firstly using threshold-free cluster 
enhancement (TFCE) and second using Bonferroni correction to account 
for the number of reference maps investigated per analysis ( p ≤ 0.003 
for RSN analysis, p ≤ 0.025 for gene map analysis, p ≤ 0.025 for tracer 
map analysis). Between-network analysis was carried out within the 
FSLNets framework using false discovery rate (FDR) correction (FM- 
RIB Software Library v5.0, fsl.fmrib.ox.ac.uk). Parametric one-sample 
t -tests were carried out in the seed-based analysis. Statistical maps are 
shown as color-coded t -statistic overlay on the AMBMC template with 
a threshold set at the TFCE and Bonferroni corrected level. Region-of- 
interest (ROI) analysis was performed using a parcellation based on the 
AIBS atlas. This was conducted as a complement to the voxel-wise anal- 
ysis to indicate the magnitude of the effect across regions of the brain. 
Statistical analysis at the ROI level was performed with a parametric 
linear model with contrast analysis and corrected with FDR. Descrip- 
tive statistics are given as mean ± 1 standard deviation. Estimation 
statistics are provided as mean differences ± 95th confidence interval 
estimated by bootstrap resampling ( https://www.estimationstats.com ) 
( Ho et al., 2019 ). 
2.4. AIBS database search 
Maps of gene expression and projection field were obtained from 
the AIBS database ( http://mouse.brain-map.org/ ). ISH gene expression 
maps relating to genes encoding 5-HT and DA receptors were searched 
using “Htr ” and “Drd ” terms, respectively. Expression maps were se- 
lected based on the presence of detectable expression and absence 
of artefact in the reconstructed images. The maps from the follow- 
ing experiments were downloaded using the AIBS application program- 
ming interface: Htr1a 79,556,616, Htr1b 583, Htr1f 69,859,867, Htr2a 
81,671,344, Htr2c 73,636,098, Drd1 71,307,280, Drd2 81,790,728. Vi- 
ral tracer maps were obtained by selecting AIBS experiments carried out 
in lines expressing the Cre recombinase in 5-HT and DA neurons for the 
DRN (114,155,190) and VTA (160,539,283), respectively. Maps were 
spatially transformed to reference space using ANTS and normalized to 
a [0, 100] range. Injection site and white matter fibres were masked 
from tracer injection maps using white matter masks. An anatomic gene 
expression atlas (AGEA) correlation map denoting the correlation be- 
tween the gene expression profile obtained from a seed region in the 
ventral striatum and that of the gene expression profiles across every 
remaining voxel in the brain was obtained from the AIBS database. In 
effect, an AGEA map indicates the degree of resemblance in gene ex- 
pression across the whole brain relative to a target region. The cor- 
relations were established on the basis of 4376 ISH maps previously 
selected for genes expressed in the brain ( Lein et al., 2007 ). A Spear- 
man’s rank correlation was used to compare the spatial overlap of the 
AGEA map to the seed-based map estimated with a seed in the ven- 
tral striatum. Additional comparisons between ISH maps and the 17 ref- 
erences RSNs were also performed with Spearman’s rank correlations. 
The significance of a correlation between Drd2 or Htr2a gene expression 
maps and individual RSN maps was determined as the 95th percentile 
of a null distribution estimated using the remaining 4374 ISH gene ex- 
pression maps (the original 4376 ISH maps minus those for Drd2 and 
Htr2a ). 
3. Results 
3.1. Psilocybin predominantly affects functional connectivity within the 
ventral striatum 
To test for potential confounding cardiovascular-mediated effects of 
psilocybin on brain FC, heart rate was monitored in a separate group 
of mice using electrocardiogram recordings and applying the same 
protocol as for the MRI experiment. Heart rate was 302 ± 30 beats 
per minute (bpm) in mice ( n = 5) that received 2 mg/kg psilocybin 
and 296 ± 27 bpm in mice ( n = 5) that received vehicle; psilocybin 
was without a significant effect on heart rate therefore (two-sample t - 
test, t = 0.32, p -value = 0.75), consistent with observations in humans 
( Hasler et al., 2004 ). 
Using the 17 RSNs established with ICA in a previous study ( Fig. 3 a) 
( Zerbi et al., 2015 ), dual-regression analysis identified that psilocybin 
led to reduced FC within the ventral striatum network of approximately 
37%, with the effect similar at the two psilocybin doses ( Fig. 1 , mean 
difference 1 mg/kg minus Veh = − 15.21 ± [ − 21.67, − 8.22], mean differ- 
ence 2 mg/kg minus Veh = − 13.35 ± [ − 20.85, − 5.16]). As for the ventral 
striatum, also for other RSNs there was no significant dose-dependent 
psilocybin effect, and therefore the two dose groups were pooled to en- 
hance statistical power and the analysis run again. The psilocybin effect 
of reduced FC in the ventral striatum was robust and reproducible, as the 
two subsets revealed similar results (Fig. S2). Psilocybin effects on FC 
were obtained within three additional RSNs, the piriform cortex, dor- 
sal striatum and lateral striatum (Fig. S3); however, these effects did 
not survive the second stage of statistical correction, namely Bonferroni 
threshold. We did not detect an effect in components overlapping with 
the DMN, namely the prefrontal and cingulate cortices, dorsal striatum, 
and ventral hippocampus. In a network analysis, there were no signif- 
icant psilocybin effects on between-network FCs for any pair of RSNs 
after full correction. We conclude that the striatal networks, and in par- 
ticular the ventral striatum RSN, were the most responsive to psilocybin, 
therefore. 
3.2. Ventral striatum RSN overlaps with a gene cluster characterized by 
high DA receptor gene expression 
Recent work has demonstrated a tight link between resting-state 
fMRI RSNs and spatial patterns of gene expression ( Richiardi et al., 
2015 ). To investigate the evidence for regions of gene expression clus- 
ters overlapping with regions sensitive to psilocybin, we compared func- 
tional connectivity to gene expression patterns obtained in untreated 
male mice ( Lein et al., 2007 ). Specifically, we examined the connectiv- 
ity and the gene expression relative to the highest t -value voxel in the 
statistical map, which corresponded to the ventral striatum area ( Fig. 1 ) 
and denotes the peak location of the psilocybin effect. The resultant 
seed-based maps for ventral striatum FC were consistent with the spatial 
delineation of the corresponding reference RSN in the ICA atlas estab- 
lished for untreated mice ( Fig. 2 ) ( Zerbi et al., 2015 ). The gene expres- 
sion profiles of 4376 genes in brain tissues were extracted from the same 
seed region as above, and compared to those of the remaining voxels in 
the brain. This determined a cluster of voxels co-expressing the same 
genes. The gene expression correlation map overlapped with the seed- 
based map for these ventral striatum voxels (rho = 0.356), indicative of 
a conserved topology between gene expression and intrinsic functional 
activity. This gene expression cluster was enriched with, among other 
genes, those encoding for the D1 and D2 receptors (2.709 and 2.871 fold 
increase in Drd1 and Drd2 expression, respectively, compared with vox- 
els outside the cluster; the list of top enriched genes is available in Table 
S1). This indicates that the RSN predominantly affected by psilocybin is 
enriched in DA receptors. 
J. Grandjean, D. Buehlmann, M. Buerge et al. NeuroImage 225 (2021) 117456 
Fig. 1. a) Reference map for the ventral striatum RSN and (b) statistical non-parametric maps estimated with dual-regression indicating decreased FC within the 
striatal RSN and extending to the pallidum in the psilocybin groups (1 mg/kg, 2 mg/kg) relative to vehicle. c) Network strength extracted from the ventral striatum 
in the 3 groups. A comparable mean difference was found in both psilocybin groups relative to the control group. Reference RSN is shown as color-coded overlays. 
Statistical non-parametric maps are shown as color-coded t- statistics ( p < 0.05 corrected with TFCE and Bonferroni correction). Mean differences are plotted as 
bootstrap sampling distributions. Black dots indicate mean differences. Vertical error bars indicate 95th confidence intervals. Vehicle n = 15, psilocybin 1 mg/kg 
n = 13, psilocybin 2 mg/kg n = 12. 
Fig. 2. a) One-sample t -test maps performed in vehicle-treated mice ( n = 15) for seed-based FC maps estimated with a 2 × 2 voxel seed region placed in the ventral 
striatum (asterisk), which was found to display the highest level of significance regarding psilocybin effects (see Fig. 1 ). FC relative to the seed co-localizes with the 
ventral striatum in the vehicle group. b) The gene co-expression cluster obtained from the anatomic gene expression atlas (AGEA) for the same seed indicates voxels 
with correlating gene expression patterns to the seed voxel. c) Its spatial extent overlaps with the FC cluster. Voxel-wise comparison across all brain voxels resulted 
in a moderate correlation between the two maps (rho = 0.356). Seed-based FC maps are shown as t- statistics ( p < 0.05 uncorrected), Gene co-expression is shown as 
color-coded correlation coefficient relative to the seed. 
3.3. 5-HT2A and D2 receptor expressions are localized in different RSNs 
The previous analysis identified that the ventral striatum network 
overlapped with a gene co-expression cluster enriched in DA recep- 
tors as well as other genes involved in DA signaling (Table S1). 
Next, the analysis was extended to investigate the inter-relationships 
between the remaining RSNs and the gene expression maps for 5- 
HT2A ( Htr2a ) and D2 ( Drd2 ) receptors, two candidate receptors in- 
volved in mediating the effects of psilocybin. D2 was selected be- 
cause psilocybin decreased the binding potential of the D2 PET lig- 
and 11 C-raclopride indicating increased receptor occupancy by en- 
dogenous dopamine ( Vollenweider, 1999 ), and 5-HT2A is the main 
target of psilocin ( Halberstadt and Geyer, 2011 ; Nichols, 2004 ) and 
necessary for its hallucinogenic effects ( González-Maeso et al., 2007 ; 
Vollenweider et al., 1998 ). To test for spatial associations of RSNs with 
either Drd2 or Htr2a expression, Spearman rank correlation was cal- 
culated for each of the 17 RSNs ( Fig. 3 a) and the gene expression 
maps extracted from the AIBS database ( Figs. 3 b,c and S4a). Signifi- 
cance was assessed relative to a null distribution generated from the 
Spearman rank correlations between each RSN and the gene expression 
maps for the other 4374 genes expressed in brain tissues ( Fig. 3 d). The 
Drd2 gene expression map was significantly spatially correlated with 
the dorsal, lateral, and ventral striatum networks (rho = [0.47, 0.34, 
0.41], p -value = [0.004, 0.008, 0.001], respectively). For the Htr2a 
gene expression map, significant spatial correlations were observed with 
the piriform cortex, prefrontal cortex, and ventral striatum networks 
(rho = [0.29, 0.22, 0.20], p -value = [0.03, 0.03, 0.04], respectively). We 
conclude that Htr2a and Drd2 are expressed within these distinct RSNs. 
Interestingly, the ventral striatum network, presenting the strongest 
within-network psilocybin effect, was found to overlap with both re- 
ceptor expression profiles. 
3.4. Using 5-HT and DA gene expression and projection field to increase 
acuity of analysis of psilocybin effects on resting-state FC 
To differentiate the effects of psilocybin on 5-HT- and DA-associated 
networks across the whole brain, a dual-regression analysis was carried 
with brain-wide Drd2 and Htr2a gene expressions used as spatial refer- 
ence maps ( Figs. 4 a, b and S4a). The averaged resting BOLD time series 
from the regions delineated in these reference maps were extracted and 
used to establish FC between these reference regions and the remain- 
ing voxels across the whole-brain. The dual-regression analysis revealed 
reduced FC between the Drd2 expressing regions and the striatum, pal- 
lidum and thalamus in psilocybin versus vehicle-treated mice ( Fig. 4 a 
and b), as detected both in the voxel-wise and complementary ROI anal- 
yses. This is comparable to the results obtained previously using RSN as 
spatial reference maps ( Fig. 1 ). A weak opposite effect, i.e. increased 
FC due to psilocybin, was found between Htr2a expressing regions and 
the left dorsal striatum, although this effect did not survive statistical 
correction in the subsequent ROI analysis ( Fig. 4 b). Analyses carried 
out for other 5-HT receptor gene-expression maps did not reveal sig- 
nificant clusters. To confirm these results, we used viral tracer maps, 
obtained by virus injection targeting DA neurons in the VTA or 5-HT 
neurons in the DRN, as spatial references in the dual-regression analy- 
sis ( Figs. 4 c, d and S4b). In agreement with the results based on gene 
expression levels, psilocybin induced a significant decrease in FC be- 
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Fig. 3. a) The 17 reference mouse brain RSNs b) Correlation between Drd2 gene expression map and the RSNs indicate significant correlations for the dorsal, ventral, 
and lateral striatum networks (dStr, lStr, vStr). Correlations below the significance threshold are shown in light shades. c) Correlation between Htr2a gene expression 
map and the RSNs indicates significant correlations in the piriform (Pir) and prefrontal (Pfc) cortex networks and the vStr network. d) A null distribution denoting 
the spatial correlation between 4374 gene expression and the prefrontal cortex or ventral striatum are represented as grey histograms. These report the distribution 
of the correlation coefficients between the RSN spatial map and a sample of gene expression maps selected for their expression in brain tissues. The dashed lines 
indicate the 95th percentile of that null distribution used as a significance threshold, red lines indicate value for correlation to Drd2 gene expression map, and blue 
lines to Htr2a gene expression map. 
tween the VTA projection fields and the medial and posterior subfields 
of the striatum. In contrast, psilocybin administration increased FC be- 
tween the DRN projection fields and the dorsal striatum, retrosplenial 
cortex, visual cortex, thalamus and midbrain. This is interpreted as an 
increase in the signal coherence between networks spatially-defined by 
DRN projections and the loci highlighted in the statistical maps. Differ- 
ences between the outcomes of the gene expression-based and projection 
field-base dual-regression analysis may be due to the lower quality of 
the gene expression maps used as spatial references (Fig. S4), as well as 
functional specialization based on receptor distribution within the pro- 
jection fields of midbrain nuclei. We conclude that psilocybin adminis- 
tration exerts differential effects on 5-HT- and DA-associated networks; 
namely, it increases FC between the 5-HT system and several striatal, 
cortical, and thalamic regions, and decreases FC between the DA sys- 
tem and striatal regions. It is noteworthy that the 5-HT-related effects 
were not detected when applying conventional RSN analysis, i.e. ex- 
amining within-network and between-network FC relative to ICA-based 
reference mouse RSNs. Hence, the inclusion of prior information con- 
cerning the origins and projection pathways of specific neurotransmit- 
ter systems, based on gene expression patterns and/or structural con- 
nectivity derived from viral tracer maps, can enhance the sensitivity of 
FC analysis. 
4. Discussion 
We hypothesized that psilocybin administration would decrease FC 
in the murine DMN-, similar to the effects observed in the human DMN 
( Carhart-Harris et al., 2013 , 2012 ). However, this was not apparent in 
the initial analysis. Instead, psilocybin reduced FC in the ventral stria- 
tum. According to gene expression maps, the RSN ventral striatum is 
enriched in DA receptors and, to a lesser extent, 5-HT2A receptors. We 
then devised a novel analytical approach based on pre-defined projec- 
tion fields derived from gene expression patterns and viral tracing maps 
to evaluate specific associations of 5-HT and DA-associated regions with 
estimated resting-state FC in the corresponding RSNs. This identified 
distinct effects of psilocybin on RSNs enriched in these two monoamine 
systems; namely, psilocybin increased FC between 5-HT-associated re- 
gions and striatal, thalamic, midbrain areas and cortical areas associated 
with the mouse DMN, and decreased FC between the DA associated re- 
gions and striatal RSNs. 
The DMN is considered to be one of the most important sys- 
tems underlying higher cognitive functions ( Raichle et al., 2001 ), and 
within- and between-region FC is increased in depression ( Sheline et al., 
2010 ) and animal models thereof ( Grandjean et al., 2016 ). In hu- 
man volunteers receiving either psilocybin or placebo, Carhart-Harris 
and colleagues reported psilocybin-induced reduction of FC between 
the DMN regions prefrontal cortex and posterior cingulate cortex 
( Carhart-Harris et al., 2012 ), increase in FC between the DMN and 
task-positive networks ( Carhart-Harris et al., 2013 ), and a general in- 
crease in between-networks FC ( Roseman et al., 2014 ). In patients with 
treatment-resistant depression, psilocybin was shown to normalize DMN 
activity ( Carhart-Harris et al., 2017 ). These studies indicate that the 
DMN is the main target for psilocybin-mediated effects. In mice, by con- 
trast, psilocybin effects on the DMN RSNs were minor compared to the 
effects on the ventral striatum. This apparent discrepancy could be in 
part due to species-specific differences in psilocybin pharmacology and 
methodologies. Firstly, in a rat study, Spain et al. (2015) estimated that a 
dose of 0.03 mg/kg psilocin, psilocybin’s active metabolite, corresponds 
to the 2 mg psilocybin dose administered in the human studies carried 
by Carhart-Harris and colleagues ( Spain et al., 2015 ). However, they 
did not observe a drug-induced change in the BOLD signal at this dose. 
In a pilot study using 0.5 mg/kg psilocybin in mice, we only detected 
weak effects on mouse striatal RSN FC recapitulating the results pre- 
sented above (Fig. S5). At a higher psilocin dose of 2 mg/kg, Spain et al. 
observed reduced BOLD signal relative to baseline in the cingulate and 
retrosplenial cortical regions and increased BOLD signal in the amyg- 
dala and hypothalamus ( Spain et al., 2015 ). Our present findings agree 
in part with these: we observed increased FC between regions express- 
ing Htr2a and the cingulate and retrosplenial cortices; however, we did 
not observe effects within the amygdala or hypothalamus. Both of these 
latter regions are located ventrally in the brain and are therefore suscep- 
tible to exposure to magnetic susceptibility gradients leading to geomet- 
ric distortion and BOLD signal loss (intravoxel dephasing, Fig. S1). This 
can render signal detection somewhat variable in these regions and may 
account for the discrepancies. Second, in contrast to human studies, the 
rodent fMRI studies conducted with psilocybin to-date have used anaes- 
thesia. Even though light anaesthesia was used here, interaction with 
the action of psilocybin cannot be excluded. This could be particularly 
the case for higher-order cortical networks, such as the mouse analogue 
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Fig. 4. a) Statistical non-parametric maps showing psilocybin effect relative to vehicle for dual-regression analysis carried out with gene expression maps as spatial 
references. FC was reduced between Drd2 gene expressing regions and in the striatum, pallidum, and thalamus in the psilocybin groups relative to vehicle. A small 
cluster was present in the striatum denoting an increase in FC between Htr2a expressing regions and this striatum in the psilocybin groups relative to vehicle. b) A ROI 
analysis was used to confirm the presence of significant effects of psilocybin in ROIs found in the striatum, pallidum and thalamus relative to Drd2 expressing regions, 
denoting decreased FC in the psilocybin mice relative to controls. There was no significant effect relative to Htr2a expression regions. c) Statistical non-parametric 
maps obtained using the VTA and DRN projection fields as reference maps. Reduced FC is observed between the striatum and pallidum, and regions receiving VTA 
projection, in the psilocybin groups relative to vehicle. Increased FC is observed between the dorsal striatum, retrosplenial cortex, visual cortex, thalamus, and 
midbrain, and regions receiving DRN projections, in the psilocybin groups relative to vehicle. d) ROI analysis confirms the presence of significant effects relative 
to VTA and DRN projection fields. Statistical non-parametric maps are shown as color-coded t- statistics ( p < 0.05 corrected with FDR and Bonferroni correction). 
Bar plots indicate t- statistics for parameter estimate comparisons extracted using AIBS Atlas ROIs. Values below the significance threshold (FDR corrected) are 
shown in light shades. Color labels indicate ontological structures: OLF = Olfactory areas, HPF = Hippocampal formation, CTXsp = Cortical sub-plate, STR = Striatum, 
PAL = Pallidum, Thal = Thalamus, Hypo-thal = Hypothalamus, CB = Cerebellum. Reference spatial maps used to delineate Drd2- and Htr2a-expressing regions, as well 
as VTA and DRN projections are indicated in Fig. S4. 
of the DMN, which reportedly are affected by under light anaesthesia 
( Deshpande et al., 2010 ; Wang et al., 2015 ). 
Psilocin, the active metabolite of psilocybin, is a 5-HT analogue and 
has been shown to bind to 5-HT2A and 5-HT1A receptors, and with 
lesser affinity to other 5-HT receptors ( Halberstadt and Geyer, 2011 ; 
Nichols, 2004 ). The expression of 5-HT2A receptors on pyramidal glu- 
tamate neurons in the cortex was demonstrated as necessary and suffi- 
cient for induction of hallucinogen-specific behavioural responses (head 
twitch, ear scratch) in mice following i.v. administration of 5-HT2A 
agonists including psilocybin ( González-Maeso et al., 2007 ). In hu- 
man, psilocybin effects on the DA system have been demonstrated by 
a PET study: psilocybin led to decreased D2 receptor occupancy by 11 C- 
raclopride, consistent with an increase in endogenous dopamine, in the 
dorsal striatum ( Vollenweider, 1999 ). Using microdialysis, psilocin was 
shown to increase DA release in the ventral striatum of rats, whereas 
5-HT release in this region was not affected. However, psilocybin did 
increase 5-HT release in the prefrontal cortex ( Sakashita et al., 2015 ). 
These observations are in line with the psilocybin-induced reduced FC 
within DA-associated regions observed in our study and suggest a po- 
tential mechanism for the reduced FC within the striatum, namely in- 
creased DA release in this region. Importantly, the analysis framework 
developed in this study, using either structural projections or gene ex- 
pression data concurrently with fMRI analyses, may allow for the over- 
coming of apparent limitations imposed by the generic physiological 
nature of the resting-state BOLD signal. Associating distinct FC pat- 
terns to either gene expression or structural connectivity priors facil- 
itates the identification of receptor-specific or nucleus-specific contri- 
butions to FC. These analytical methods are complementary to those 
that apply optogenetics or chemogenetics to regulate monoamine re- 
lease and study effects thereon of brain-wide hemodynamic responses 
( Giorgi et al., 2017 ; Grandjean et al., 2019 ). 
We are aware of potential limitations associated with our approach. 
Firstly, psilocin administration has been associated with decoupling be- 
tween the hemodynamic response and neuronal activity in rats during 
short-duration, high frequency ( > 10 Hz) whisker sensory stimulation 
( Spain et al., 2015 ); however, this was not the case for lower frequency 
paradigms. Moreover, this effect would not be expected to be confined 
to specific RSNs, hence the relevance of this observation in the con- 
text of resting-state FC remains moot. Second, database resources of 
gene expression or viral tracer maps differ in map coverage and qual- 
ity. Image artefact or misregistration could impact the analysis when 
used as priors. For instance, only a subset of the 5-HT gene expression 
maps available on the AIBS database met our quality assurance crite- 
rion, restricting the scope of our analysis to this subset of 5-HT genes. 
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In addition, the receptor maps often correlate with one another (e.g. 
D1 and D2 receptor), making it difficult to infer precise mechanisms in- 
volving one or the other receptor without the use of pharmacological 
or genetic interventions. We have also used a relatively high dose of 
psilocybin compared to studies in humans ( Carhart-Harris et al., 2012 ). 
Species-specific pharmacokinetic and pharmacodynamic properties may 
account for the large difference in drug dose required to elicit pharma- 
cological responses in humans and rodents. Interestingly, both doses led 
to a comparable effect, potentially indicative of a ceiling effect; however 
half the lower dose used in this study failed to evoke a detectable signal 
in a pilot study. Overall, therefore, the findings suggest that there is a 
rather narrow dose-range within which psilocybin effects on RSNs can 
be detected. Finally, we have opted for a robust statistical approach to 
mitigate false positives ( Eklund et al., 2016 ), albeit potentially at the 
expense of increased false-negative rates. 
In conclusion, we have demonstrated robust effects of psilocybin on 
FC within the striatal RSNs. Incorporation of neurotransmitter-specific 
gene expression and viral tracer maps into our analysis enabled further 
refinement. In particular, we found differential psilocybin effects in 5- 
HT versus DA associated networks: increased FC in the cortex, including 
DMN-associated areas, thalamus, and midbrain attributed to 5-HT ver- 
sus decreased FC in the striatum, a DA projection area rich in D2 recep- 
tors. While the implication of DMN nodes in our analysis supports our 
original hypothesis, this effect was comparatively small in comparison 
to the effect on FC within the ventral striatum. Finally, we demonstrate 
the application of a novel analytical approach to refine the interpreta- 
tion of FC changes in RSNs. Including information on gene expression 
and viral tracer maps, available from large neuroscience databases, in 
the analysis of neuroimaging data, allows for the annotation of FC data 
with a molecular signature, and thereby provides mechanistic insight 
into factors involved in normal and pathological network functioning. 
CRediT authorship contribution statement 
Joanes Grandjean: Conceptualization, Methodology, Formal anal- 
ysis, Investigation, Data curation, Writing - original draft. David 
Buehlmann: Investigation, Writing - review & editing. Michaela 
Buerge: Investigation, Writing - review & editing. Hannes Sigrist: 
Methodology, Investigation, Writing - review & editing. Erich Seifritz: 
Conceptualization, Writing - review & editing. Franz X. Vollen- 
weider: Conceptualization, Resources, Writing - review & editing. 
Christopher R. Pryce: Conceptualization, Methodology, Writing - re- 
view & editing, Funding acquisition. Markus Rudin: Conceptualization, 
Methodology, Writing - review & editing, Funding acquisition. 
Funding and disclosure 
This research was supported by a fellowship grant for JG from the 
Swiss Foundation for Excellence and Talent in Biomedical Research (to 
CRP and MR), and by project grants 31003A-141137 (to CRP and ES) 
and 310030-160310 (to MR) from the Swiss National Science Founda- 
tion. The authors have no financial disclosure to declare. 
Supplementary materials 
Supplementary material associated with this article can be found, in 
the online version, at doi:10.1016/j.neuroimage.2020.117456 . 
References 
Avants, B.B., Tustison, N.J., Song, G., Cook, P.A., Klein, A., Gee, J.C., 2011. A reproducible 
evaluation of ANTs similarity metric performance in brain image registration. Neu- 
roImage. doi: 10.1016/j.neuroimage.2010.09.025 . 
Carhart-Harris, R.L. , Erritzoe, D. , Williams, T. , Stone, J.M. , Reed, L.J. , Colasanti, A. , Ty- 
acke, R.J. , Leech, R. , Malizia, A.L. , Murphy, K. , Hobden, P. , Evans, J. , Feilding, A. , 
Wise, R.G. , Nutt, D.J. , 2012. Neural correlates of the psychedelic state as determined 
by fMRI studies with psilocybin. Proc. Natl. Acad. Sci. U. S. A. 109, 2138–2143 . 
Carhart-Harris, R.L., Leech, R., Erritzoe, D., Williams, T.M., Stone, J.M., Evans, J., 
Sharp, D.J., Feilding, A., Wise, R.G., Nutt, D.J., 2013. Functional connectivity mea- 
sures after psilocybin inform a novel hypothesis of early psychosis. Schizophr. Bull. 
doi: 10.1093/schbul/sbs117 . 
Carhart-Harris, R.L., Leech, R., Hellyer, P.J., Shanahan, M., Feilding, A., Tagliazucchi, E., 
Chialvo, D.R., Nutt, D., 2014. The entropic brain: a theory of conscious states in- 
formed by neuroimaging research with psychedelic drugs. Front. Hum. Neurosci. 
doi: 10.3389/fnhum.2014.00020 . 
Carhart-Harris, R.L., Roseman, L., Bolstridge, M., Demetriou, L., Nienke Pannekoek, J., 
Wall, M.B., Tanner, M., Kaelen, M., McGonigle, J., Murphy, K., Leech, R., Valerie 
Curran, H., Nutt, D.J., 2017. Psilocybin for treatment-resistant depression: fMRI- 
measured brain mechanisms. Sci. Rep. doi: 10.1038/s41598-017-13282-7 . 
Damoiseaux, J.S., S A, R., Barkhof, F., Scheltens, P., Stam, C.J., Smith, S.M., Beck- 
mann, C.F., 2006. Consistent resting-state networks across healthy subjects. Proc. 
Natl. Acad. Sci. U. S. A. doi: 10.1073/pnas.0601417103 . 
Deshpande, G., Kerssens, C., Sebel, P.S., Hu, X., 2010. Altered local coher- 
ence in the default mode network due to sevoflurane anesthesia. Brain Res. 
doi: 10.1016/j.brainres.2009.12.075 . 
Eklund, A. , Nichols, T.E. , Knutsson, H. , 2016. Cluster failure: why fMRI inferences for 
spatial extent have inflated false-positive rates. Proc. Natl. Acad. Sci. U. S. A. 113, 
7900–7905 . 
Filippini, N. , MacIntosh, B.J. , Hough, M.G. , Goodwin, G.M. , Frisoni, G.B. , Smith, S.M. , 
Matthews, P.M. , Beckmann, C.F. , Mackay, C.E. , 2009. Distinct patterns of brain activ- 
ity in young carriers of the APOE-epsilon4 allele. Proc. Natl. Acad. Sci. U. S. A. 106, 
7209–7214 . 
Giorgi, A. , Migliarini, S. , Galbusera, A. , Maddaloni, G. , Mereu, M. , Margiani, G. , Gritti, M. , 
Landi, S. , Trovato, F. , Bertozzi, S.M. , Armirotti, A. , Ratto, G.M. , De Luca, M.A. , 
Tonini, R. , Gozzi, A. , Pasqualetti, M. , 2017. Brain-wide mapping of endogenous sero- 
tonergic transmission via chemogenetic fMRI. Cell Rep. 21, 910–918 . 
González-Maeso, J., Weisstaub, N.V., Zhou, M., Chan, P., Ivic, L., Ang, R., Lira, A., Bradley- 
Moore, M., Ge, Y., Zhou, Q., Sealfon, S.C., Gingrich, J.A., 2007. Hallucinogens recruit 
specific cortical 5-HT2A receptor-mediated signaling pathways to affect behavior. 
Neuron doi: 10.1016/j.neuron.2007.01.008 . 
Gozzi, A. , Schwarz, A.J. , 2016. Large-scale functional connectivity networks in the rodent 
brain. Neuroimage 127, 496–509 . 
Grandjean, J. , Azzinnari, D. , Seuwen, A. , Sigrist, H. , Seifritz, E. , Pryce, C.R. , Rudin, M. , 
2016. Chronic psychosocial stress in mice leads to changes in brain functional con- 
nectivity and metabolite levels comparable to human depression. Neuroimage 142, 
544–552 . 
Grandjean, J. , Canella, C. , Anckaerts, C. , Ayranc ı , G. , Bougacha, S. , Bienert, T. , 
Buehlmann, D. , Coletta, L. , Gallino, D. , Gass, N. , Garin, C.M. , Nadkarni, N.A. , Hüb- 
ner, N.S. , Karatas, M. , Komaki, Y. , Kreitz, S. , Mandino, F. , Mechling, A.E. , Sato, C. , 
Sauer, K. , Shah, D. , Strobelt, S. , Takata, N. , Wank, I. , Wu, T. , Yahata, N. , Yeow, L.Y. , 
Yee, Y. , Aoki, I. , Chakravarty, M.M. , Chang, W.-.T. , Dhenain, M. , von Elverfeldt, D. , 
Harsan, L.-.A. , Hess, A. , Jiang, T. , Keliris, G.A. , Lerch, J.P. , Meyer-Lindenberg, A. , 
Okano, H. , Rudin, M. , Sartorius, A. , Van der Linden, A. , Verhoye, M. , Weber-Fahr, W. , 
Wenderoth, N. , Zerbi, V. , Gozzi, A. , 2020. Common functional networks in the mouse 
brain revealed by multi-centre resting-state fMRI analysis. Neuroimage 205, 116278 . 
Grandjean, J. , Corcoba, A. , Kahn, M.C. , Upton, A.L. , Deneris, E.S. , Seifritz, E. , Helm- 
chen, F. , Mann, E.O. , Rudin, M. , Saab, B.J. , 2019. A brain-wide functional map of 
the serotonergic responses to acute stress and fluoxetine. Nat. Commun. 10, 350 . 
Grandjean, J., Schroeter, A., Batata, I., Rudin, M., 2014. Optimization of anesthesia proto- 
col for resting-state fMRI in mice based on differential effects of anesthetics on func- 
tional connectivity patterns. NeuroImage doi: 10.1016/j.neuroimage.2014.08.043 . 
Griffiths, R.R., Johnson, M.W., Carducci, M.A., Umbricht, A., Richards, W.A., 
Richards, B.D., Cosimano, M.P., Klinedinst, M.A., 2016. Psilocybin produces sub- 
stantial and sustained decreases in depression and anxiety in patients with 
life-threatening cancer: a randomized double-blind trial. J. Psychopharmacol. 
doi: 10.1177/0269881116675513 . 
Grob, C.S., Danforth, A.L., Chopra, G.S., Hagerty, M., McKay, C.R., Halberstadt, A.L., 
Greer, G.R., 2011. Pilot study of psilocybin treatment for anxiety in patients 
with advanced-stage cancer. Arch. Gen. Psychiatry doi: 10.1001/archgenpsychia- 
try.2010.116 . 
Halberstadt, A.L., Geyer, M.A., 2011. Multiple receptors contribute to the 
behavioral effects of indoleamine hallucinogens. Neuropharmacology 
doi: 10.1016/j.neuropharm.2011.01.017 . 
Hasler, F., Grimberg, U., Benz, M.A., Huber, T., Vollenweider, F.X., 2004. Acute 
psychological and physiological effects of psilocybin in healthy humans: a 
double-blind, placebo-controlled dose? Effect study. Psychopharmacology 
doi: 10.1007/s00213-003-1640-6 . 
Hawrylycz, M.J. , Lein, E.S. , Guillozet-Bongaarts, A.L. , Shen, E.H. , Ng, L. , Miller, J.A. , van 
de Lagemaat, L.N. , Smith, K.A. , Ebbert, A. , Riley, Z.L. , Abajian, C. , Beckmann, C.F. , 
Bernard, A. , Bertagnolli, D. , Boe, A.F. , Cartagena, P.M. , Chakravarty, M.M. , 
Chapin, M. , Chong, J. , Dalley, R.A. , David Daly, B. , Dang, C. , Datta, S. , Dee, N. , Dol- 
beare, T.A. , Faber, V. , Feng, D. , Fowler, D.R. , Goldy, J. , Gregor, B.W. , Haradon, Z. , 
Haynor, D.R. , Hohmann, J.G. , Horvath, S. , Howard, R.E. , Jeromin, A. , Jochim, J.M. , 
Kinnunen, M. , Lau, C. , Lazarz, E.T. , Lee, C. , Lemon, T.A. , Li, L. , Li, Y. , Morris, J.A. , 
Overly, C.C. , Parker, P.D. , Parry, S.E. , Reding, M. , Royall, J.J. , Schulkin, J. , Se- 
queira, P.A. , Slaughterbeck, C.R. , Smith, S.C. , Sodt, A.J. , Sunkin, S.M. , Swanson, B.E. , 
Vawter, M.P. , Williams, D. , Wohnoutka, P. , Zielke, H.R. , Geschwind, D.H. , Hof, P.R. , 
Smith, S.M. , Koch, C. , Grant, S.G.N. , Jones, A.R. , 2012. An anatomically comprehen- 
sive atlas of the adult human brain transcriptome. Nature 489, 391–399 . 
Ho, J. , Tumkaya, T. , Aryal, S. , Choi, H. , Claridge-Chang, A. , 2019. Moving beyond p values: 
data analysis with estimation graphics. Nat. Methods 16, 565–566 . 
Kundu, P., Inati, S.J., Evans, J.W., Luh, W.-.M., Bandettini, P.A., 2012. Differentiating 
BOLD and non-BOLD signals in fMRI time series using multi-echo EPI. NeuroImage 
doi: 10.1016/j.neuroimage.2011.12.028 . 
J. Grandjean, D. Buehlmann, M. Buerge et al. NeuroImage 225 (2021) 117456 
Lein, E.S. , Hawrylycz, M.J. , Ao, N. , Ayres, M. , Bensinger, A. , Bernard, A. , Boe, A.F. , Bo- 
guski, M.S. , Brockway, K.S. , Byrnes, E.J. , Chen, L. , Chen, L. , Chen, T.-.M. , Chin, M.C. , 
Chong, J. , Crook, B.E. , Czaplinska, A. , Dang, C.N. , Datta, S. , Dee, N.R. , Desaki, A.L. , 
Desta, T. , Diep, E. , Dolbeare, T.A. , Donelan, M.J. , Dong, H.-.W. , Dougherty, J.G. , 
Duncan, B.J. , Ebbert, A.J. , Eichele, G. , Estin, L.K. , Faber, C. , Facer, B.A. , Fields, R. , 
Fischer, S.R. , Fliss, T.P. , Frensley, C. , Gates, S.N. , Glattfelder, K.J. , Halverson, K.R. , 
Hart, M.R. , Hohmann, J.G. , Howell, M.P. , Jeung, D.P. , Johnson, R.A. , Karr, P.T. , 
Kawal, R. , Kidney, J.M. , Knapik, R.H. , Kuan, C.L. , Lake, J.H. , Laramee, A.R. , 
Larsen, K.D. , Lau, C. , Lemon, T.A. , Liang, A.J. , Liu, Y. , Luong, L.T. , Michaels, J. , Mor- 
gan, J.J. , Morgan, R.J. , Mortrud, M.T. , Mosqueda, N.F. , Ng, L.L. , Ng, R. , Orta, G.J. , 
Overly, C.C. , Pak, T.H. , Parry, S.E. , Pathak, S.D. , Pearson, O.C. , Puchalski, R.B. , 
Riley, Z.L. , Rockett, H.R. , Rowland, S.A. , Royall, J.J. , Ruiz, M.J. , Sarno, N.R. , 
Schaffnit, K. , Shapovalova, N.V. , Sivisay, T. , Slaughterbeck, C.R. , Smith, S.C. , 
Smith, K.A. , Smith, B.I. , Sodt, A.J. , Stewart, N.N. , Stumpf, K.-.R. , Sunkin, S.M. , 
Sutram, M. , Tam, A. , Teemer, C.D. , Thaller, C. , Thompson, C.L. , Varnam, L.R. , 
Visel, A. , Whitlock, R.M. , Wohnoutka, P.E. , Wolkey, C.K. , Wong, V.Y. , Wood, M. , Yay- 
laoglu, M.B. , Young, R.C. , Youngstrom, B.L. , Yuan, X.F. , Zhang, B. , Zwingman, T.A. , 
Jones, A.R. , 2007. Genome-wide atlas of gene expression in the adult mouse brain. 
Nature 445, 168–176 . 
Ng, L., Bernard, A., Lau, C., Overly, C.C., Dong, H.-.W., Kuan, C., Pathak, S., Sunkin, S.M., 
Dang, C., Bohland, J.W., Bokil, H., Mitra, P.P., Puelles, L., Hohmann, J., Ander- 
son, D.J., Lein, E.S., Jones, A.R., Hawrylycz, M., 2009. An anatomic gene expression 
atlas of the adult mouse brain. Nat. Neurosci. doi: 10.1038/nn.2281 . 
Nichols, D.E., 2004. Hallucinogens. Pharmacol. Ther. 
doi: 10.1016/j.pharmthera.2003.11.002 . 
Oh, S.W. , Harris, J.A. , Ng, L. , Winslow, B. , Cain, N. , Mihalas, S. , Wang, Q. , Lau, C. , Kuan, L. , 
Henry, A.M. , Mortrud, M.T. , Ouellette, B. , Nguyen, T.N. , Sorensen, S.A. , Slaughter- 
beck, C.R. , Wakeman, W. , Li, Y. , Feng, D. , Ho, A. , Nicholas, E. , Hirokawa, K.E. , 
Bohn, P. , Joines, K.M. , Peng, H. , Hawrylycz, M.J. , Phillips, J.W. , Hohmann, J.G. , 
Wohnoutka, P. , Gerfen, C.R. , Koch, C. , Bernard, A. , Dang, C. , Jones, A.R. , Zeng, H. , 
2014. A mesoscale connectome of the mouse brain. Nature 508, 207–214 . 
Raichle, M.E., MacLeod, A.M., Snyder, A.Z., Powers, W.J., Gusnard, D.A., Shul- 
man, G.L., 2001. A default mode of brain function. Proc. Natl. Acad. Sci. U. S. A. 
doi: 10.1073/pnas.98.2.676 . 
Richiardi, J. , Altmann, A. , Milazzo, A.-.C. , Chang, C. , Chakravarty, M.M. , Ba- 
naschewski, T. , Barker, G.J. , Bokde, A.L.W. , Bromberg, U. , Büchel, C. , Conrod, P. , 
Fauth-Bühler, M. , Flor, H. , Frouin, V. , Gallinat, J. , Garavan, H. , Gowland, P. , Heinz, A. , 
Lemaître, H. , Mann, K.F. , Martinot, J.-.L. , Nees, F. , Paus, T. , Pausova, Z. , Rietschel, M. , 
Robbins, T.W. , Smolka, M.N. , Spanagel, R. , Ströhle, A. , Schumann, G. , Hawry- 
lycz, M. , Poline, J.-.B. , Greicius, M.D. IMAGEN consortium, 2015. Brain networks. Cor- 
related gene expression supports synchronous activity in brain networks. Science 348, 
1241–1244 . 
Roseman, L. , Leech, R. , Feilding, A. , Nutt, D.J. , Carhart-Harris, R.L. , 2014. The effects of 
psilocybin and MDMA on between-network resting state functional connectivity in 
healthy volunteers. Front. Hum. Neurosci. 8, 204 . 
Sakashita, Y., Abe, K., Katagiri, N., Kambe, T., Saitoh, T., Utsunomiya, I., Horiguchi, Y., 
Taguchi, K., 2015. Effect of psilocin on extracellular dopamine and serotonin levels 
in the mesoaccumbens and mesocortical pathway in awake rats. Biol. Pharm. Bull. 
doi: 10.1248/bpb.b14-00315 . 
Sforazzini, F., Schwarz, A.J., Galbusera, A., Bifone, A., Gozzi, A., 2014. Distributed 
BOLD and CBV-weighted resting-state networks in the mouse brain. NeuroImage 
doi: 10.1016/j.neuroimage.2013.09.050 . 
Sheline, Y.I., Price, J.L., Yan, Z., Mintun, M.A., 2010. Resting-state functional MRI in 
depression unmasks increased connectivity between networks via the dorsal nexus. 
Proc. Natl. Acad. Sci. U. S. A. doi: 10.1073/pnas.1000446107 . 
Spain, A., Howarth, C., Khrapitchev, A.A., Sharp, T., Sibson, N.R., Mar- 
tin, C., 2015. Neurovascular and neuroimaging effects of the hallucinogenic 
serotonin receptor agonist psilocin in the rat brain. Neuropharmacology 
doi: 10.1016/j.neuropharm.2015.07.018 . 
Stafford, J.M., Jarrett, B.R., Miranda-Dominguez, O., Mills, B.D., Cain, N., Mihalas, S., 
Lahvis, G.P., Matthew Lattal, K., Mitchell, S.H., David, S.V., Fryer, J.D., Nigg, J.T., 
Fair, D.A., 2014. Large-scale topology and the default mode network in the mouse 
connectome. Proc. Natl. Acad. Sci. U. S. A. doi: 10.1073/pnas.1404346111 . 
Vollenweider, F., 1999. 5-HT modulation of dopamine release in basal ganglia in 
psilocybin-induced psychosis in man —a PET study with [11C]raclopride. Neuropsy- 
chopharmacology doi: 10.1016/s0893-133x(98)00108-0 . 
Vollenweider, F.X., Leenders, K.L., Scharfetter, C., Antonini, A., Maguire, P., 
Missimer, J., Angst, J., 1997. Metabolic hyperfrontality and psychopathol- 
ogy in the ketamine model of psychosis using positron emission tomogra- 
phy (PET) and [18F]fluorodeoxyglucose (FDG). Eur. Neuropsychopharmacol. 
doi: 10.1016/s0924-977x(96)00039-9 . 
Vollenweider, F.X., Vollenweider-Scherpenhuyzen, M.F.I., Bäbler, A., Vogel, H., Hell, D., 
1998. Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 
agonist action. NeuroReport doi: 10.1097/00001756-199812010-00024 . 
Wang, B., Liu, X., Li, H., Luo, F., Zhang, L., Han, R., 2015. Variation of the default mode 
network with altered alertness levels induced by propofol. Neuropsychiatr. Dis. Treat. 
doi: 10.2147/ndt.s88156 . 
Zerbi, V. , Grandjean, J. , Rudin, M. , Wenderoth, N. , 2015. Mapping the mouse brain with 
rs-fMRI: an optimized pipeline for functional network identification. Neuroimage 123, 
11–21 . 
